We see the future in cells
An AI-First company with a mission to revolutionise cell-based therapeutic development with the power of AI
Cell-based development is slow, costly, and difficult to control
Traditional methods rely on endpoint assays and manual monitoring, limiting early visibility and efficient optimisation across the therapeutic pipeline.
A more predictive approach is needed
Late visibility
Critical failures only detected weeks into the process.
High variability
Inconsistent outcomes across batches and donors.
Trial-and-error
Manual iteration cycles that waste valuable time.
Costly iteration
Expensive reagents and labor lost to failed runs.
How the Cell Predictive AI Platform Works
CellVoyant combines predictive insight and process optimisation to transform biological complexity into predictable outcomes.
FateView™
Predict cell state: Label-free imaging and AI analysis to understand what cells are doing now — and what they will do next.
Learn moreFateDrive™
Optimise cell process: Model, simulate, and prioritise process conditions to guide better experimental and manufacturing decisions.
Learn moreFateView™
Our secure and cloud-based platform where you can log in, upload your cell images, and instantly receive AI-powered predictions of present & future cell states, CQAs, and likely outcomes, enabling earlier, better interventions.
- Label-free AI image analysis
- Predict current and future cell state
- Detect issues days earlier
- Enable earlier intervention
FateDrive™
An AI-driven optimisation service designed to replace trial-and-error process development with predictive, data-informed strategies.
- Simulate process variations in silico
- Identify variables that drive performance
- Prioritise optimal conditions
- Guide experimental and manufacturing decisions
- Work alongside your team on science-led optimisation
Synergy: Integrate predictive inputs from FateView™ to enable real-time, closed-loop optimisation.
From prediction to action — in one system
CellVoyant enables adaptive process control by combining real-time measurement with model-driven optimisation.
Learn moreIntegration
Your Workflow
Optimisation
FateDrive™
Prediction
FateView™
Measurable impact across your development pipeline
Up to 60%
Fewer failed experiments
Identifying differentiation failure before typical assays.
Up to 8×
Higher yield
Optimising harvest timing and process consistency.
Up to 40%
Less waste
Through fewer assay runs and less consumable use.
Results observed across internal studies and partner workflows
Our partners and recognition
Our growing network of partners, alongside recognition for innovation in the field.
Accelerate your cell process optimisation
Discover how prediction and optimisation can transform your workflows and improve outcomes across your pipeline.
The Team
Scientists and innovators building the technologies that make next-generation cell therapies possible.
Rafael Carazo Salas
CEO & Founder
Eugenia Wachters
COO
Mark Chadwick
Executive Chair
Saad Mohamad
ML / AI Science Lead
Elisa Pedone
Stem Cell Operations Lead
Adel Benamara
ML Engineer Lead
Rickard Sjögren
AI Project Manager
Edward Ren
Senior Imaging Scientist
Robert van Dijk
AI Solutions Scientist
Chris Gribben
Senior Stem Cell Scientist
Tunde Berecz
Stem Cell Scientist
Karunya Balasubramaniam
Laboratory Technician
Sami Pegg
ML Engineer
Yi-Hsiang Huang
Software Engineer
Florin Moraru
MLOps Engineer
Elaine Williams
Operations Manager
Lucy Templeman
Executive Assistant to the CEO